Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 8.01, 9.01 · 8-K

AmperCap Acquisition Company

APMCNASDAQEQUITYCurrent

Other Events

Item 8.01. Other Events. On June 4, 2026, AmperCap Acquisition Company (the “ Company ”) consummated its initial public offering (“ IPO ”) of 12,500,000 units (the “ Units ”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $125,000,000.…

Filed Jun 18, 2026Accepted Jun 18, 2026, 4:15 PM EDTCIK 2101393Accession 0001185185-26-002588
Share

Company context

Current securities

Historical securities (3)

Recent company filings

  1. SCHEDULE 13G/A - filed by Sculptor Capital LP regarding AmperCap Acquisition CoNov 13, 2026
  2. 10-Q filingNov 13, 2026
  3. SCHEDULE 13G/A - filed by Magnetar Financial LLC regarding AmperCap Acquisition CoNov 13, 2026
  4. SCHEDULE 13G - filed by WOLVERINE ASSET MANAGEMENT LLC regarding AmperCap Acquisition CoOct 7, 2026
  5. 10-Q filingAug 13, 2026

Registered securities in this filing

AmperCap Acquisition Company · 8-K · Filed 2026-06-18

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Units, each consisting of one ordinary share and one right

Symbol
APMCU
Exchange
NASDAQ
Classification
UNIT
Status
Current
Filing context

Context: From2026-06-042026-06-04_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember

Dimensions: us-gaap:StatementClassOfStockAxis

Ordinary shares, par value $0.0001 per share

Symbol
APMC
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: From2026-06-042026-06-04_custom_OrdinarySharesParValue0.0001PerShareMember

Dimensions: us-gaap:StatementClassOfStockAxis

Rights, each right entitling the holder to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination

Symbol
APMCR
Exchange
NASDAQ
Classification
RIGHT
Filing context

Context: From2026-06-042026-06-04_custom_RightsEachRightEntitlingHolderToReceiveOnetenth110OfOneOrdinaryShareUponConsummationOfInitialBusinessCombinationMember

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000118518526002588 · 3 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events. On June 4, 2026, AmperCap Acquisition Company (the “ Company ”) consummated its initial public offering (“ IPO ”) of 12,500,000 units (the “ Units ”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $125,000,000. Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “ Ordinary Shares ”), and one right to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the Company’s initial business combination (each, a “ Share Right ”). Simultaneously with the closing of the IPO, the Company completed the private sale (the “ Private Placement ”) of an aggregate of 512,500 units (the “ Private Placement Units ”) to AmperSPAC LLC, the Company’s sponsor (the “ Sponsor ”), EarlyBirdCapital, Inc., the representative of the Company’s underwriters in the IPO (“ EBC ”), and certain third-party investors at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $5,125,000. In connection with the IPO, the underwriters were granted a 45-day option from the date of the prospectus (the “ Over-Allotment Option ”) to purchase up to 1,875,000 additional units to cover over-allotments (the “ Option Units ”), if any. On June 10, 2026, the underwriters purchased an additional 1,837,500 Option Units pursuant to the partial exercise of the Over-Allotment Option. The remaining 37,500 Option Units will not be exercised. The Option Units were sold at an offering price of $10.00 per Unit, generating additional gross proceeds to the Company of $18,375,000. In connection with the closing of the Over-Allotment Option, the Sponsor and EBC purchased an additional 55,125 Private Placement Units in the aggregate at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $551,250. Following the closing of the IPO and the Over-Allotment Option, a total of approximately $144,808,750 of the proceeds from the sale of the Units, the Option Units, and the Private Placement Units was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company acting as trustee. An audited balance sheet as of June 4, 2026 reflecting the receipt of the proceeds from the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K. Forfeiture of Founder Shares As previously disclosed on a Current Report on Form 8-K dated June 12, 2026, on June 8, 2026, the underwriters informed the Company that they would not exercise the remainder of their over-allotment option and on June 10, 2026, 12,500 founder shares of the Company held by the Sponsor were forfeited by the Sponsor. On June 10, 2026, an aggregate of 717 founder shares of the Company held by EBC and its designees were also forfeited by EBC and such designees.
Filed exhibits (1)
EX-99.1 (by filename) acacex99-1.htm

EX-99.1 2 acacex99-1.htm EXHIBIT 99.1 Exhibit 99.1 AMPERCAP ACQUISITION COMPANY INDEX TO FINANCIAL STATEMENT Report F-2 of Independent Registered Public Accounting Firm Balance F-3 Sheet as of June 4, 2026 Notes F-4 to Financial Statement F-1 Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of AmperCap Acquisition Company Opinion on the Financial Statements We have audited the accompanying balance sheet of AmperCap Acquisition Company (the “Company”) as of June 4, 2026, and the related notes (collectively referred to as the “financial statement”). In our opinion, the financial statement presents fairly, in all material respects, the financial position of the Company as of June 4, 2026, in conformity with accounting principles generally accepted in the United States of America. Basis for Opinion This financial statement is the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statement based on our audit.…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.